Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edwards Lifesciences (EW)
NYSE:EW
Edwards Lifesciences (EW) Ownership Overview
0.93% Insiders
21.34% Mutual Funds
18.83% Other Institutional Investors
24.48% ETFs
34.42% Public Companies and Individual Investors
The ownership structure of Edwards Lifesciences (EW) stock is a mix of institutional, retail, and individual investors. Approximately 64.65% of the company’s stock is owned by Institutional Investors, 0.93% is owned by Insiders, and 34.42% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 14, 2025 | Steven Loranger Director | xxxxxxxxxxxxx | $438574 |
| Feb 13, 2025 | Heisz Leslie Stone Director | xxxxxxxxxxxxx | $435361 |
| Dec 06, 2024 | Wayne Markowitz Gm & Svp, Surgical | xxxxxxxxxxxxx | $42716 |
| Dec 06, 2024 | Daveen Chopra Cvp, Tmtt | xxxxxxxxxxxxx | $128223 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $7106 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $47749 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $806408 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $3701500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 63,278,859 | Institution | 10.73% | 4,821,216,267 | |
| 50,692,552 | Institution | 8.59% | 3,862,265,537 | |
| 32,448,262 | Institution | 5.50% | 2,472,233,082 | |
| 21,458,958 | Institution | 3.64% | 1,634,958,010 | |
| 15,905,459 | Institution | 2.70% | 1,211,836,921 | |
| 9,809,563 | Institution | 1.66% | 747,390,605 | |
| 9,775,276 | Institution | 1.66% | 744,778,278 | |
| 7,133,719 | Institution | 1.21% | 543,518,051 | |
| 5,704,893 | Institution | 0.97% | 434,655,798 | |
| 4,174,752 | Institution | 0.71% | 318,074,355 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 50,692,552 | Institution | 8.59% | 3,862,265,537 | |
| 15,905,459 | Institution | 2.70% | 1,211,836,921 | |
| 9,809,563 | Institution | 1.66% | 747,390,605 | |
| 4,174,752 | Institution | 0.71% | 318,074,355 | |
| 3,367,762 | Institution | 0.57% | 256,589,787 | |
| 3,315,775 | Institution | 0.56% | 252,628,897 | |
| 3,003,837 | Institution | 0.51% | 228,862,341 | |
| 2,749,725 | Institution | 0.47% | 209,501,548 | |
| 1,987,118 | Institution | 0.34% | 151,398,520 | |
| 1,761,733 | Institution | 0.30% | 134,226,437 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,493,193 | Institution | 3.14% | 1,369,051,078 | |
| 15,971,999 | Institution | 2.71% | 1,182,407,086 | |
| 12,680,542 | Institution | 2.15% | 938,740,524 | |
| 7,229,046 | Institution | 1.23% | 549,407,496 | |
| 7,229,046 | Institution | 1.23% | 549,407,496 | |
| 6,920,166 | Institution | 1.17% | 527,247,448 | |
| 4,369,995 | Institution | 0.74% | 323,510,730 | |
| 4,187,484 | Institution | 0.71% | 318,248,784 | |
| 3,314,059 | Institution | 0.56% | 245,339,788 | |
| 2,910,160 | Institution | 0.49% | 221,725,090 |
FAQ
Who Owns Edwards Lifesciences (EW)?
According to the latest TipRanks data, approximately 18.83% of the company's stock is held by institutional investors, 0.93% is held by insiders, and 34.42% is held by retail investors.
What percentage of Edwards Lifesciences (EW) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.83% of Edwards Lifesciences (EW) stock is held by institutional investors.
What percentage of Edwards Lifesciences (EW) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.42% of Edwards Lifesciences (EW) stock is held by retail investors.
Who owns the most shares of Edwards Lifesciences (EW)?
Vanguard owns the most shares of Edwards Lifesciences (EW).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.